サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1777647

尿路感染症検査の世界市場

Urinary Tract Infection Testing

出版日
ページ情報
英文 300 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
尿路感染症検査の世界市場
出版日: 2025年07月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 300 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

尿路感染症検査の世界市場は2030年までに7億2,370万米ドルに達する見込み

2024年に6億1,250万米ドルと推定される尿路感染症検査の世界市場は、分析期間2024～2030年にCAGR 2.8%で成長し、2030年には7億2,370万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである尿道炎は、CAGR 2.1％を記録し、分析期間終了時には3億9,000万米ドルに達すると予測されます。膀胱炎セグメントの成長率は、分析期間中CAGR 3.9％と推定されます。

米国市場は1億6,690万米ドルと推定、中国はCAGR 5.2％で成長すると予測

米国の尿路感染症検査市場は、2024年に1億6,690万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年にかけてCAGR 5.2%で推移し、2030年には1億3,960万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.1%と2.1%と予測されています。欧州では、ドイツがCAGR 1.6%で成長すると予測されています。

世界の尿路感染症（UTI）検査市場- 主要動向と促進要因のまとめ

尿路感染症の世界の負担増が診断需要の急増を後押しする

尿路感染症（UTI）は、世界的に最も一般的な細菌感染症の一つであり、毎年数億人に影響を与え、診断検査の大幅な増加につながっています。特に女性、高齢者、糖尿病、腎臓病、免疫不全の人々の間で、あらゆる年齢層で尿路結石の発生率が増加しているため、迅速で正確な検査ソリューションに対する需要が持続的に高まっています。早期診断と抗菌薬スチュワードシップに対する意識が高まるにつれ、ヘルスケアシステムは、病院の負担を軽減し、抗生物質の過剰処方を最小限に抑えるために、ポイントオブケア診断への投資を増やしています。尿路結石の再発や合併は、カテーテルの使用や尿路の構造的な異常と関連していることが多く、入院・外来を問わず診断処置の件数が増加する一因となっています。さらに、ヘルスケア関連感染症（HAI）の世界の増加、特に長期療養施設における増加により、信頼性の高い尿路結石スクリーニングプロトコルの必要性が高まっています。臨床医が無症候性細菌尿と真の感染症を区別することを目指す中、治療の意思決定を正確に導くことができる、より特異的で感度の高い検査に需要がシフトしています。このような進化する臨床状況は、診断検査機関、プライマリ・ケア提供者、緊急医療センターが尿路結石検出の能力を拡大することを後押しし、世界の尿路結石検査市場の成長を促進しています。

技術の進歩とPOC診断はどのように尿路結石検査を変革しているか？

技術革新は、スピード、正確性、アクセシビリティの重視の高まりとともに、尿路感染症検査の状況を劇的に変化させています。従来の培養に基づく方法は、信頼性は高いもの、結果が出るまでに24～48時間を要し、徐々に迅速診断に補完され、あるいは取って代わられつつあります。最新の尿ディップスティック検査や尿検査キットは、亜硝酸塩、白血球エステラーゼ、その他の重要な感染指標を迅速に検出できるようになり、救急外来やプライマリ・ケアの現場で貴重なツールとなっています。さらに、分子診断、特にPCRベースの検査は、特定の病原体や耐性遺伝子の迅速な同定を可能にし、診断の精度を大幅に向上させ、適切な抗生物質の処方を支援しています。ポイント・オブ・ケア（POC）プラットフォームは、その携帯性、使いやすさ、リアルタイムで結果を提供する能力から、特に農村部や資源が限られた環境ではますます普及しています。自動尿分析装置もまた、ワークフローを合理化し、手作業によるミスを減らし、ハイスループット検査を可能にするために臨床検査室に統合されつつあります。さらに、スマートフォン接続機器やAI主導の診断ツールは、特に慢性感染症や再発性感染症の患者を対象とした、在宅での尿路結石モニタリングのための新たなソリューションとして台頭してきています。これらの技術的進歩は、診断精度を最適化するだけでなく、臨床医がエビデンスに基づく個別化された治療戦略に移行するのを助け、最終的には抗生物質耐性や感染症の再発の負担を軽減します。

ヘルスケアモデルと消費者行動の変化は尿路結石検査の市場を拡大するか？

ヘルスケアシステムが患者中心の分散型ケアへと進化するにつれ、尿路感染症検査は、小売クリニック、在宅検査環境、遠隔医療主導型の診断プラットフォームなど、従来とは異なる環境で実施されるようになってきています。消費者は今日、利便性、スピード、機密性-特に尿路結石のようなデリケートな症状-を求めています。特に尿路結石のようなデリケートな症状ではなおさらです。このため、市販またはオンラインで購入でき、プライバシーと迅速な自己スクリーニングを提供する家庭用尿路結石検査キットが普及しています。これらのキットは多くの場合、比色ストリップ技術やアプリに接続されたセンサーを利用しており、ユーザーが結果を正確に解釈し、医療機関を受診するタイミングを決めるのに役立っています。遠隔医療プロバイダーも尿路結石検査を需要の高いサービスとして受け入れており、多くの場合、直接受診することなく、症状や検査の確認結果に基づいて抗生物質を処方しています。さらに、雇用主や大学では、産業保健やウェルネス・プログラムの一環として尿路結石スクリーニング・サービスを提供しており、従来の臨床環境を超えて検査がさらに拡大しています。医療機関側では、病院、介護施設、リハビリテーションセンターにおける早期発見と感染対策が重視され、定期的なスクリーニングとカテーテル治療後のモニタリングが推進されています。このようなケア環境の拡大は、健康管理への患者の関与の増大と並んで、尿路結石検査のダイナミックで急速に多様化する市場を促進し、この需要を満たすための新しい検査形式や流通モデルの開発を促しています。

尿路感染症検査市場の世界的成長の原動力は？

尿路感染症検査市場の成長は、臨床ニーズ、技術進歩、人口動向、ヘルスケア提供の進化と結びついた複数の収束要因によって牽引されています。特に、女性、高齢者、慢性疾患や留置カテーテルを持つ患者など、一貫して患者層が拡大している人々の間で、尿路結石症が世界的に増加していることが大きな推進力となっています。これと並行して、未治療の尿路結石（腎臓感染、敗血症、慢性再発など）の危険性に対する認識が高まり、検査の早期化・頻回化が進んでいます。抗菌薬耐性の加速化も、抗生物質処方前の診断をより正確にすることを促し、ヘルスケアプロバイダーに迅速かつ病原体特異的な検査の採用を促しています。分子技術やデジタル技術の役割の増大は、手頃な価格のポイント・オブ・ケア検査キットや家庭用検査キットの入手可能性の増大と相まって、診断の範囲を拡大し、アクセスの障壁を減らしています。有利な規制の枠組み、支援的な償還政策、感染症サーベイランスを推進する公衆衛生イニシアチブは、検査イノベーションと市場成長を可能にする環境を作り出しています。さらに、遠隔医療、モバイル診断、DaaS（diagnostic-as-a-service）プラットフォームの台頭により、遠隔地や十分なサービスを受けていない人々への尿路結石検査の提供が拡大しています。このような動向が進化を続ける中、尿路感染症検査市場は、臨床的緊急性、患者のエンパワーメント、診断イノベーションという複合的な要請を原動力として、力強く持続的な拡大を遂げる態勢を整えています。

セグメント

タイプ（尿道炎、膀胱炎、腎盂腎炎）;エンドユース（一般開業医、泌尿器科医、泌尿器科医、病院検査室、リファレンス検査室、病院救急部、救急医療、その他）

調査対象企業の例

  • Accelerate Diagnostics, Inc.
  • Acutis Diagnostics
  • Becton, Dickinson and Company（BD）
  • Beckman Coulter
  • bioMerieux
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin
  • F. Hoffmann-La Roche Ltd.
  • GENETWORx
  • Healthy.io
  • Patients Choice Laboratories
  • QIAGEN
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • T2 Biosystems, Inc.
  • TestCard
  • Thermo Fisher Scientific, Inc.
  • Uritest Medical
  • Winx

AIインテグレーション

私たちは、検証された専門家のコンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP33210

Global Urinary Tract Infection Testing Market to Reach US$723.7 Million by 2030

The global market for Urinary Tract Infection Testing estimated at US$612.5 Million in the year 2024, is expected to reach US$723.7 Million by 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Urethritis, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$390.0 Million by the end of the analysis period. Growth in the Cystitis segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$166.9 Million While China is Forecast to Grow at 5.2% CAGR

The Urinary Tract Infection Testing market in the U.S. is estimated at US$166.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$139.6 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Urinary Tract Infection (UTI) Testing Market - Key Trends & Drivers Summarized

Is the Rising Global Burden of UTIs Fueling a Surge in Diagnostic Demand?

Urinary tract infections (UTIs) are among the most common bacterial infections globally, impacting hundreds of millions of people annually and leading to a substantial increase in diagnostic testing. The growing incidence of UTIs across all age groups-particularly among women, the elderly, and individuals with diabetes, kidney conditions, or immunocompromised states-is driving sustained demand for rapid and accurate testing solutions. As awareness of early diagnosis and antimicrobial stewardship increases, healthcare systems are investing more in point-of-care diagnostics to reduce the burden on hospitals and minimize the overprescription of antibiotics. Recurrent and complicated UTIs, often associated with catheter use or structural abnormalities in the urinary tract, further contribute to the growing volume of diagnostic procedures in both inpatient and outpatient settings. Additionally, the global rise in healthcare-acquired infections (HAIs), particularly in long-term care facilities, is heightening the need for reliable UTI screening protocols. As clinicians aim to differentiate between asymptomatic bacteriuria and true infection, demand is shifting toward more specific and sensitive tests that can accurately guide treatment decisions. This evolving clinical landscape is pushing diagnostic laboratories, primary care providers, and urgent care centers to expand their capabilities in UTI detection, driving growth in the global UTI testing market.

How Are Technological Advancements and POC Diagnostics Transforming UTI Testing?

Technological innovation is dramatically reshaping the urinary tract infection testing landscape, with a growing emphasis on speed, accuracy, and accessibility. Traditional culture-based methods, though highly reliable, require 24-48 hours for results and are gradually being supplemented or replaced by rapid diagnostics. Modern urine dipstick tests and urinalysis kits now offer quicker detection of nitrites, leukocyte esterase, and other key indicators of infection, making them valuable tools in emergency departments and primary care settings. Additionally, molecular diagnostics-particularly PCR-based tests-are enabling the rapid identification of specific pathogens and resistance genes, significantly improving the precision of diagnosis and supporting appropriate antibiotic prescribing. Point-of-care (POC) platforms are becoming increasingly popular due to their portability, user-friendliness, and ability to deliver real-time results, particularly in rural or resource-limited environments. Automated urine analyzers are also being integrated into clinical laboratories to streamline workflows, reduce manual error, and allow for high-throughput testing. Furthermore, smartphone-connected devices and AI-driven diagnostic tools are emerging as novel solutions for home-based UTI monitoring, especially for patients with chronic or recurrent infections. These technological advancements are not only optimizing diagnostic accuracy but also helping clinicians move toward evidence-based, individualized treatment strategies, ultimately reducing the burden of antibiotic resistance and recurrent infections.

Are Shifting Healthcare Models and Consumer Behaviors Expanding the Market for UTI Testing?

As healthcare systems evolve toward decentralized, patient-centered care, urinary tract infection testing is increasingly being conducted in non-traditional settings such as retail clinics, home testing environments, and telehealth-driven diagnostic platforms. Consumers today demand convenience, speed, and confidentiality-especially for sensitive conditions like UTIs. This has led to the proliferation of at-home UTI test kits, which can be purchased over the counter or online, offering privacy and rapid self-screening. These kits often utilize colorimetric strip technologies or app-connected sensors that help users interpret results accurately and decide when to seek medical attention. Telemedicine providers have also embraced UTI testing as a high-demand service, often prescribing antibiotics based on symptoms and test confirmations without the need for an in-person visit. Additionally, employers and universities are offering UTI screening services as part of occupational health and wellness programs, further expanding testing beyond traditional clinical environments. On the institutional side, the emphasis on early detection and infection control in hospitals, nursing homes, and rehabilitation centers is driving routine screening and post-catheterization monitoring. This expansion of care settings-alongside greater patient involvement in health management-is fostering a dynamic and rapidly diversifying market for UTI testing, encouraging the development of new test formats and distribution models to meet this demand.

What Is Driving the Global Growth of the Urinary Tract Infection Testing Market?

The growth in the urinary tract infection testing market is driven by multiple converging factors tied to clinical need, technological progress, demographic trends, and healthcare delivery evolution. A major driver is the global increase in UTI prevalence, particularly among women, the elderly, and individuals with chronic illnesses or indwelling catheters, all of whom represent a consistent and expanding patient base. In parallel, rising awareness around the dangers of untreated UTIs-such as kidney infections, sepsis, and chronic recurrence-is prompting earlier and more frequent testing. The acceleration of antimicrobial resistance is also encouraging more precise diagnosis before antibiotic prescription, pushing healthcare providers to adopt rapid and pathogen-specific tests. The growing role of molecular and digital technologies, combined with the increased availability of affordable point-of-care and home-based test kits, is enhancing diagnostic reach and reducing access barriers. Favorable regulatory frameworks, supportive reimbursement policies, and public health initiatives promoting infectious disease surveillance are creating an enabling environment for testing innovation and market growth. Furthermore, the rise of telehealth, mobile diagnostics, and diagnostic-as-a-service (DaaS) platforms is expanding the availability of UTI testing to remote and underserved populations. As these trends continue to evolve, the urinary tract infection testing market is poised for strong and sustained expansion, driven by the combined imperatives of clinical urgency, patient empowerment, and diagnostic innovation.

SCOPE OF STUDY:

The report analyzes the Urinary Tract Infection Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Urethritis, Cystitis, Pyelonephritis); End-Use (General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories, Hospital Emergency Departments, Urgent Care, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Accelerate Diagnostics, Inc.
  • Acutis Diagnostics
  • Becton, Dickinson and Company (BD)
  • Beckman Coulter
  • bioMerieux
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin
  • F. Hoffmann-La Roche Ltd.
  • GENETWORx
  • Healthy.io
  • Patients Choice Laboratories
  • QIAGEN
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • T2 Biosystems, Inc.
  • TestCard
  • Thermo Fisher Scientific, Inc.
  • Uritest Medical
  • Winx

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Urinary Tract Infection Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising UTI Prevalence Among Aging and At-Risk Populations Spurs Global Testing Demand
    • Growth in Recurrent and Complicated UTI Cases Strengthens Business Case for Rapid and Accurate Diagnostics
    • Increased Awareness and De-Stigmatization of Urinary Health Expands Addressable Market Opportunity
    • Shift Toward Point-of-Care and Home Testing Solutions Drives Adoption in Non-Clinical Settings
    • Technological Advancements in Molecular Diagnostics Propel Innovation in UTI Test Accuracy and Speed
    • Expansion of Telehealth Platforms Throws the Spotlight on Remote UTI Diagnosis and Testing Integration
    • Widespread Antibiotic Resistance Crisis Accelerates Demand for Pathogen-Specific UTI Testing
    • Consumer Preference for Privacy and Convenience Generates Growth in Over-the-Counter UTI Test Kits
    • Incorporation of AI and Digital Health Tools Enhances Decision Support and Test Interpretation Accuracy
    • Rising Healthcare-Associated UTI Incidence in Hospitals and Long-Term Care Sustains Demand for Surveillance Testing
    • Availability of UTI Testing Through Online Pharmacies and E-Commerce Channels Expands Patient Access
    • Integration of UTI Testing into Preventive and Women's Health Programs Creates New Growth Avenues
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Urinary Tract Infection Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Urinary Tract Infection Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Urethritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Urethritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Urethritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cystitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cystitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cystitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pyelonephritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pyelonephritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Pyelonephritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Urgent Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Urgent Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Urgent Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for General Practitioners by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for General Practitioners by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for General Practitioners by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Urologists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Urologists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Urologists by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Urogynecologists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Urogynecologists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Urogynecologists by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Hospital Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospital Emergency Departments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospital Emergency Departments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospital Emergency Departments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • JAPAN
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • CHINA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • EUROPE
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Urinary Tract Infection Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • FRANCE
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • GERMANY
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Spain 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Spain 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Russia 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Russia 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Urinary Tract Infection Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Australia 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Australia 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • INDIA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 128: India Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: India 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 131: India Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: India 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: South Korea 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: South Korea 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Urinary Tract Infection Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Latin America 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Argentina 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Argentina 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Brazil 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Brazil 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Mexico 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Mexico 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Urinary Tract Infection Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Urinary Tract Infection Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Middle East 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Iran 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Iran 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Israel 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Israel 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: UAE 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: UAE 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030
  • AFRICA
    • Urinary Tract Infection Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Urinary Tract Infection Testing by Type - Urethritis, Cystitis and Pyelonephritis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Africa 15-Year Perspective for Urinary Tract Infection Testing by Type - Percentage Breakdown of Value Sales for Urethritis, Cystitis and Pyelonephritis for the Years 2015, 2025 & 2030
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Urinary Tract Infection Testing by End-Use - Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Africa 15-Year Perspective for Urinary Tract Infection Testing by End-Use - Percentage Breakdown of Value Sales for Urgent Care, Others, General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories and Hospital Emergency Departments for the Years 2015, 2025 & 2030

IV. COMPETITION